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Screening mammographies in Switzerland:
what makes female and male physicians 
prescribe them?1
B. Keller, E. Zemp Stutz, M. Tibblin, U. Ackermann-Liebrich, K. Faisst, Nicole Probst-Hensch
Institute of Social and Preventive Medicine, Basel, Switzerland
Question under study: Physicians play a key role
in motivating women to undergo mammography
screening. In 1998 we assessed Swiss physicians’
attitudes to mammography screening and their
prescription behaviour in this regard. 
Methods: All female physicians and every sec-
ond male physician aged 50–69 who were either
not board-certified or board-certified in general
practice, internal medicine, or obstetrics/gynae-
cology were sent a questionnaire. The response
rate was 50% and thus 738 questionnaires were
included in this study. Of the study population
39% were female and 61% male physicians. The
distribution of professional backgrounds was: 27%
board-certified general practitioners; 23% board-
certified internists; 11% board-certified gynaecol-
ogists; 39% not board-certified. 
Results: 55% of all study participants were in
favour of a mammography screening programme
for women aged over 50 in Switzerland, but breast
self-examination and clinical breast examination
were judged to have a more positive impact on
breast cancer survival. Among clinically practising
physicians, 22% reported generally prescribing
biannual screening mammographies for women
aged 50–69. Irrespective of other determinants,
physicians from the Italian- and French-speaking
parts of Switzerland prescribed screening mam-
mographies more often than their colleagues from
the German-speaking part (odds ratio [OR] 2.5;
95% confidence interval [CI] 1.5–4.2). Clinical
practice in obstetrics/gynaecology (OR 2.4; CI
1.3–4.2) and a self-reported high level of knowl-
edge concerning mammography screening (OR
1.9; CI 1.1–3.2) were also positively associated
with the prescription of screening mammography. 
Conclusions: Since mammography screening
programmes exist in only three French-speaking
cantons of Switzerland (VS; VD; GE), the gap in
prescription of screening mammographies be-
tween French/Italian- and German-speaking re-
gions must be narrowed to prevent a higher preva-
lence of side effects from opportunistic screening
among German-speaking women. There is a need
to educate physicians and the political community
regarding the risks and benefits of mammography
screening.
Keywords: mammographic screening; physicians; pre-
scription; attitude
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Summary
Introduction
Breast cancer is the most common cancer in
women. One in twelve women in Switzerland will
develop breast cancer over their lifetime [1]. Most
breast cancer risk factors identified so far are poor
targets for primary prevention of the disease [2].
Early detection therefore plays a crucial role in the
fight against breast cancer. Mammography is the
only screening method clearly associated with a
reduction in breast cancer mortality in well-de-
signed studies. Mortality reductions of up to 30%
have been identified in eight randomised inter-
vention studies in women aged 50 to 65 years who
were screened at 1–3-year intervals [3, 4].
An effective reduction in breast cancer mor-
tality associated with both an improved quality of
life in breast cancer patients and a reduced risk of
side effects [5, 6] in screened women can only be
achieved with quality-controlled screening pro-
grammes. In Switzerland women aged 50 and over
undergoing biannual mammographic screening in
the context of a programme fulfilling the legal
quality control criteria [7] are reimbursed by their
health insurance schemes. Since such programmes
are available in only three cantons (Vaud, Geneva,
Valais), women from other cantons have access
only to opportunistic screening and are thus faced
with an increased risk of side effects [8]. In fact,
according to the data of the 1997 Swiss Health
Survey, more women in the French-speaking part
undergo mammography than in the German-
speaking region [9]. Physicians in general – but
most importantly physicians in cantons lacking
screening programmes – who provide care to peri-
and postmenopausal women play a crucial role 
in educating women about screening mammogra-
phy. Their central role in motivating women for
participation in mammography screening pro-
grammes has been demonstrated by several stud-
ies [10–15]. Asked for the two most common rea-
sons why they had not had a mammography,
women stated, first, that they did not know they
actually needed an exam, and, second, that the
exam was not recommended to them by their
physician [14]. 
We therefore investigated how male and fe-
male physicians in Switzerland relate to mam-
mography screening. First, we investigated their
attitude to the procedure. We focused on the age
group between 50 and 65, because our second in-
terest was in the personal mammography screen-
ing behaviour of female physicians. Third and
most importantly, we assessed the screening
mammography prescription rate and how it was
influenced by attitude, personal screening be-
haviour and other factors.
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Methods
The cross-sectional study was based on a self-
administered questionnaire sent to all practising
female (n = 529) and 50% of all practising male
physicians (n = 1001) aged 50 to 65 years who were
either not board-certified or board-certified in
general practice, internal medicine, or obstet-
rics/gynaecology. Selection of this age category
was based on our interest in assessing female
doctors’ personal screening behaviour (age at
which mammography screening is generally rec-
ommended). The professional backgrounds se-
lected chiefly cover the medical service provided
to peri- and postmenopausal women in Switzer-
land. Since many female physicians practice med-
icine without being board-certified, we included
this group in the study. Name and address (n =
1530) were provided by the Swiss Medical Associ-
ation (FMH).The first mailing was sent out in
November 1998, followed by two reminders in
December 1998 and January 1999. Questionnaires
returned before May 1999 were included in the
study. 36 participants had to be excluded from the
study (address unknown n = 5; died n = 1; no longer
practising n = 8; abroad n = 2; professional back-
ground different from those listed above n = 20).
The response rate was 58% for women and 46%
for men. 15 questionnaires were excluded (demo-
graphic information missing n = 2, or unrealistic 
n = 13). The study population is representative of
the base population with regard to age, gender, re-
gion and board-certification (table 1). We col-
lected information on demographic variables,
workplace, attitude to and prescription of mam-
mography screening and osteoporosis prevention
(manuscript in preparation). Female physicians
were also questioned about their personal breast
cancer screening strategies.
Data was anonymised and abstracted in Epi
Characteristics base population1 study population
female male total female male total
Region German 69.4% 69.1% 69.2% 75.2% 74.6% 74.8%
French 24.6% 26.2% 25.6% 23.8% 22.8% 23.2%
Italian 2.5% 3.3% 3.0% 1.0% 2.7% 2.0%
abroad 3.6% 1.4% 2.2%
Board-certification Gynaecology/Obstetrics 11.3% 12.1% 11.8% 8.3% 13.1% 11.3%
General Practice 9.6% 29.8% 22.8% 11.3% 38.0% 27.4%
Internal Medicine 13.6% 27.6% 22.7% 13.8% 28.6% 22.8%
other2 0% 1.0% 0.8%
total board-cert. 34.6% 70.4% 58.0% 33.4% 79.7% 61.5%
not board-cert. 65.4% 29.6% 42.0% 66.6% 20.3% 38.5%
Age –55 53.7% 52.1% 52.7% 52.4% 55.1% 54.0%
–60 30.4% 28.9% 29.4% 32.1% 28.4% 29.9%
–65 14.9% 17.4% 16.5% 15.5% 16.5% 16.1%
–70 0.9% 1.6% 1.4%
1 In order to assess the representativity of the study population the characteristics listed in the table were provided by the Swiss 
Medical Association (FMH)
2 Infectiology n = 3, Child and Adolescent Psychiatry n = 1, Medical Genetics n = 1, Med. Radiology/Radio-Oncology n = 1
Table 1
Comparison of base
population and study
population.
Info (Version 6.03, Januar 1996) and statistically
analysed in STATA (Statistical Software, StataCorp
1997, Release 6.0). We first investigated the fre-
quency distribution of answers related to attitude
and personal behaviour with regard to mammog-
raphy screening. Attitude refers to the question
whether the participant is in favour of health in-
surance coverage for mammography screening 
for women in Switzerland after age 50 (Appendix,
Question 1). Personal screening behaviour refers to
the question whether female physicians undergo
mammography screening themselves on a regular
basis (Appendix , Question 2). Prescription behav-
iour refers to the question whether the participant
routinely prescribes screening mammographies
for patients in specified age categories (Appendix,
Question 3). 
We first investigated the determinants of atti-
tude, personal screening behaviour and prescrip-
tion behaviour in separate statistical models. In a
second step we assessed the association of the
major determinants identified in step 1, and of
attitude and personal screening behaviour, with
prescription behaviour in a multivariate logistic
regression model. Separate models were run for 
all participants combined (general model) and for
male and female physicians separately. The mod-
els were restricted to physicians reporting they
were treating patients at the time of the interview.
Independent variables included in the models
were: age, gender (general model only), language
region, board-certification, gynaecological activ-
ity, self-reported level of knowledge concerning
mammography screening, attitude, belief in the
life-prolonging effect of mammography screen-
ing, estimation of patient knowledge (general
model only), and personal screening behaviour
(model for female physicians only).
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female male total significance
n % n % n % P1
Total 290 39.3 448 60.7 738 100.0
Region German 218 75.2 334 74.6 552 74.8 n.s.2
French 69 23.8 102 22.8 171 23.2
Italian 3 1.0 12 2.7 15 2.0
Age (years) <55 152 52.4 247 55.1 399 54.0 n.s.2
55–59 93 32.1 127 28.4 220 29.9
>59 45 15.5 74 16.5 119 16.1
Board-certification board-certified: 97 33.4 357 79.7 454 61.5 <0.0013
specialty:
Obstetrics/Gynaecology 24 8.3 59 13.1 83 11.3 0.044
General Practice 33 11.3 170 38.0 203 27.4
Internal Medicine 40 13.8 128 28.6 168 22.8
not board-certified: 193 66.6 91 20.3 284 38.5
Practising medicine yes 257 88.6 432 96.4 689 93.4 <0.0015
full-time 122 42.1 415 92.6 537 72.8
part-time 135 46.6 17 3.8 152 20.6
no 29 10.0 14 3.1 43 5.8
no reply 4 1.4 2 0.5 6 0.8
total 290 100 448 100 738 100
Workplace 5 private practice 186 72.4 356 82.4 542 78.7 n.s.2
hospital 52 20.2 79 18.3 131 19.0
other 49 19.1 35 8.1 84 12.2
no reply 9 3.5 46 10.7 55 8.0
total 257 100 432 100 689 100
1 p(χ2) for the comparison between female and male physicians
2 n.s. =  not significant (p> = 0.05)
3 Comparison between board-certified vs. not board-certified
4 Contrast between the specialties of board-certification
5 the p-value is based on combining ‘no reply’ and ‘no’ in a single category
6 these numbers only refer to participants who were practising medicine at the time of interview (n = 689). 
Multiple replies were allowed. 
Table 2 
Sociodemographic
characteristics of
male and female
physicians.
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female male total
n % n % n %
1. Breast self-examination 222 76.62 332 74.12 554 75.1
2. Clinical breast examination 213 73.43 304 67.83 517 70.0
3. Screening mammography 205 70.74 299 66.74 504 68.3
1 Question “How effective is the life-prolonging effect of screening mammography, breast self-examination, and clinical breast 
examination?” Possible replies: “ineffective”, “potentially ineffective”, “potentially effective”, “effective”. The table lists the sum 
of “potentially effective“ and “effective” replies.
2 p(χ2) for the comparison of female vs. male physicians  =  0.11. The “(potentially) ineffective” replies were compared to the 
“(potentially) effective” replies.
3 p(χ2) for the comparison of female vs. male physicians  =  0.005. The “(potentially) ineffective” replies were compared to the 
“(potentially) effective” replies.
4 p(χ2) for the comparison of female vs. male physicians  =  0.32. The “(potentially) ineffective” replies were compared to the 
“(potentially) effective” replies.
Table 3 
Percentage of female
and male physicians
who think of screen-
ing mammography,
breast self-examina-
tion and clinical
breast examination
as having a life-
prolonging effect.1
female male total significance
n % n % n % P2
Yes 165 56.9 241 53.8 406 55.0 <0.0013
No 67 23.1 154 34.4 221 30.0
No opinion 50 17.2 43 9.6 93 12.6
No reply 8 2.8 10 2.2 18 2.4
Total 290 100 448 100 738 100
1 Appendix, question 1
2 p(χ2) for the comparison of female vs. male physicians
3 In calculating this p-value the categories ‘no opinion’ and ‘no reply’ were combined; 
p(χ2) for the comparison yes vs. no after exclusion of ‘no opinion’ and ‘no reply’: p = 0.011. 
Table 4 
Attitude of female
and male physicians
towards the introduc-
tion of mammogra-
phy screening for all
women after age 50
in Switzerland.1
Results
738 questionnaires were included in the analy-
sis. Of the study population 39% were female and
61% male physicians (table 2). Three-quarters of
participants practised in the German-speaking re-
gion, about one quarter in the French-speaking re-
gion, and a very small percentage in the Italian-
speaking region. The participants’ mean age was
55 years. 33% of female and 80% of male physi-
cians were board-certified (p <0.001). Among
board-certified participants 45% were general
practitioners, 37% internists, and 18% gynaecol-
ogists. There was a statistically significant gender
difference in the distribution of specialties among
board-certified participants (p[χ2] = 0.04 ). 67% of
female and 20% of male physicians were not
board-certified. Their specialty area was chiefly
general practice and psychiatry. Overall, 93% of
participants and about half of all female physicians
were practising medicine at the time of interview.
Among those, 79% were in private practice.
Breast self-examination and clinical breast ex-
amination ranked higher than mammography
screening in the physicians’ judgement of the re-
spective impact of different breast cancer screen-
ing methods on survival (table 3). 
57% of female and 54% of male physicians were
in favour of health insurance refund for screening
mammography (table 4; Appendix, Question 1). 
More female respondents had “no opinion”
(17% vs. 10%), whereas more males were against
refund (34% vs. 23%). Arguments against screen-
ing mammography were listed in the following
order: (1) false reassurance in the light of a nega-
tive result, (2) unfavourable cost/benefit ratio, (3)
too many follow-up procedures, (4) too many
false-positive results. In bivariate analysis a statis-
tically significant positive association with ap-
proval of mammography screening programmes in
Switzerland was found for respondents practising
in French- or Italian-speaking regions (83% vs.
46%, p <0.001); practising without board-certifi-
cation (58% vs. 53%, p <0.001); practising in
gynaecology (69% vs. 53%, p = 0.009); with a self-
reported high level of knowledge of mammogra-
phy screening (65% vs. 39%, p <0.001); and with
a belief in the life-prolonging effect of mammog-
raphy screening (88% vs. 2%, p <0.001).
All female physicians were at the age at which
mammography screening is generally recom-
mended by experts. 54% reported that they
underwent regular screening mammographies
(Appendix, Question 2). Differences were again
noted between language regions (75% in the
French/Italian-speaking parts of Switzerland vs.
38% in the German-speaking part; p <0.001); be-
tween different self-reported levels of knowledge
concerning mammography screening (52% vs.
35% for high and low levels self-reported knowl-
edge respectively; p = 0.002); between differences
in belief regarding improved survival due to mam-
mography screening (70% vs. 9%, p <0.001); and
between differences in attitude to mammography
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General prescription of female male total
screening mammographies n % n % n %
Total 172 29.4 414 70.6 586 100
Yes2 70 40.7 150 36.2 220 37.5
for age category
<40 years 18 10.4 67 16.1 85 14.5
40–50 years 35 20.3 99 23.8 134 22.8
50–70 years 69 40.0 142 34.1 211 35.9
Interval3 annually 6 3.5 10 2.4 16 2.7
biannually 45 26.1 85 20.4 130 22.1
triannually 14 8.1 36 8.6 50 8.5
less often 4 2.3 10 2.4 14 2.4
no reply 0 0.0 1 0.2 1 0.2
>70 years 42 24.4 106 25.4 148 25.2
No2 87 50.6 253 61.1 340 58.0
No reply 15 8.7 11 2.7 26 4.4
1 Appendix, question 3
2 p(χ2) female vs. male physicians: «yes» versus «no» versus «no reply»: p(χ2) = 0.001«yes» versus «no»: p(χ2) = 0.109
3 Screening interval for women between ages 50 und 70 years. The gender difference with regard to screening intervals is not significant.
Table 5 
Prescription of
screening mammo-
graphies in the clini-
cally active study
population.1
screening (63% vs. 22%, p <0.001). Personal
screening behaviour was not associated with
gynaecological activity, board-certification, hor-
mone replacement therapy or a positive family his-
tory of breast cancer.
To investigate the prescription rate for screen-
ing mammography and its determinants we in-
cluded only participants who were actually treat-
ing patients. We excluded participants who were
not practising medicine at the time of interview,
who were working on a theoretical aspect of med-
icine, or who did not answer questions relating to
prescription. The clinically active group of physi-
cians made up 79% of the study population and
consisted of 172 (29%) female and 414 (71%) male
physicians.
Overall, 38% of participants (41% female and
36% male physicians) reported that they generally
recommended screening mammography to their
patients (table 5, Appendix, Question 3). These
participants were then asked about prescription
behaviour with regard to specific patient age cate-
gories. 22% (26% female and 20% male physi-
cians) prescribed screening mammographies bian-
nually for all women aged 50–70 years, in agree-
ment with general recommendations in Switzer-
land. Six percent of clinically active participants re-
ported that they would even try to prevent asymp-
tomatic patients from undergoing mammography
screening because of its potential side effects. Rea-
sons for not recommending mammography
screening were ranked as follows: beneficial effect
on overall survival not proven; beneficial effect on
the rate of breast-conserving surgery not proven,
and low acceptance among patients.
We investigated the association of sociodemo-
graphic factors, attitude and personal screening
behaviour with the likelihood of prescribing
screening mammography in a multivariate model.
The following variables were identified as inde-
pendent and statistically significant predictors (fig-
ure 1): a positive attitude towards mammography
screening (OR 4.40, 95% CI 2.6–7.5) and a belief
in its life-prolonging effect (OR 3.43, 95% CI 1.8-
6.9) were positively associated with the likelihood
of prescribing screening mammography. Physi-
cians practising in the French- or Italian-speaking
region were more likely to prescribe screening
mammographies irrespective of other predictors
(OR 2.47, 95% CI 1.5–4.2). The same was true of
physicians practising gynaecology, irrespective of
board-certification (OR 2.36, 95% CI 1.3–4.2).
Male and female physicians with a high self-re-
ported level of knowledge concerning mammog-
raphy screening prescribed it more often (OR 1.85,
95% CI 1.1–3.2), as did physicians who considered
their patients to be well informed (OR 1.73, 95%
CI 1.1–2.9). Female gender and younger age were
both positively associated with likelihood of pre-
scribing mammography screening, but not to a sta-
tistically significant extent. Stratification of the
analysis by gender identified the same predictors
of the likelihood of prescribing screening mam-
mography. Female physicians who underwent
screening mammographies themselves were more
likely to prescribe them for their patients, but the
result did not attain statistical signficance (OR 2.6,
95% CI 0.8–8.4).
Only 38% of practising male and female physi-
cians reported that they recommended screening
mammographies to women after a certain age.
Only 22% prescribed them in agreement with
Swiss guidelines in terms of starting age (50) and
screening interval (biannually). Only half of all par-
ticipants were in favour of mammography screen-
ing programmes and only half of all female physi-
cians underwent mammography screening them-
selves. Impressive differences between the French/
Italian- versus German-speaking regions were ob-
served in all three areas investigated: attitude, per-
sonal screening behaviour and likelihood of pre-
scribing mammography. This difference between
language regions is also reflected in the results of
the most recent Swiss Health Survey (Schweiz-
erische Gesundheitsbefragung 1997): the percent-
age of women who had ever undergone mammog-
raphy (including diagnostic mammography) was
25% in the eastern and central parts of Switzerland
as opposed to 48% (region of Geneva) and 46%
(Ticino) in the western part of the country [9, 16].
These figures mask the positive association be-
tween frequency of mammography and social sta-
tus. To what degree these regional differences re-
flect differences in the prevalence of mammogra-
phy screening programmes (only available in the
French-speaking region) or more fundamental dif-
ferences of attitude towards prevention in general
cannot be determined on the basis of our results.
It is interesting, though, in this context that in 1996
more family planning services were available in the
French-speaking regions, reflecting a stronger
interest in sexual and reproductive health [17].
The low prevalence of screening mammogra-
phy prescription in the age-group of the Swiss
physicians included in our study may reflect their
uncertainty with regard to the benefit of this
screening method in the light of recurrent discus-
sion of this issue [4, 18–20]. The methodology 
and results of the large randomised intervention
studies investigating the association between
mammography screening and breast cancer mor-
tality have again been criticised recently in a meta-
analysis including only 20% of the available data
[18]. The authors argue that small age differences
between the intervention groups may have been
the result of incomplete randomisation in many of
these studies. They thus question the accuracy of
the observed average 25% decrease in breast can-
cer mortality in these studies. Despite being widely
publicised, the conclusions of the metaanalysis
were immediately criticised by many national and
international experts [4, 19, 20]. The observed
small age differences between the intervention
groups cannot explain the observed difference in
breast cancer mortality across the eight large ran-
domised trials. In fact, in countries which intro-
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Figure 1 
Determinants of pre-
scription of screening
mammographies in
the clinically active
study population.
Personal
Screening
Female
Physicians
2.6 (0.8–8.4)
Attitude
4.4 (2.6–7.5)
Prescription
Behavior
Language Region
2.5 (1.5–4.2)
Gynecological Activity
2.4 (1.3–4.2)
Self-Reported Knowledge
1.9 (1.1–3.2)
Judment of
Patients’ Knowledge
1.7 (1.1–2.9)
Belief in
Life-Prolongation
3.4 (1.8–6.9s)
The numbers reflect odds ratios (OR) (95% confidence intervals) for the association of the respective variable with the like-
lihood of prescribing screening mammographies, adjusted for age and gender as well as for all other determinants in the
model:
Attitude towards (see Appendix, Question 1): positive vs. negative/no opinion (reference group)
Language region: French/Italian vs. German (reference group)
Gynaecological activity: yes (board-certified or not board-certified) vs. no (reference group)
Self-reported knowledge of mammography: high/very high level vs. poor/very poor/not reported (reference group)
Belief in life-prolongation (see question in footnote to Table 3): effective/ potentially effective vs. ineffective/potentially
ineffective (reference group)
Judgement of patients’ knowledge: average/high level vs. poor/not reported (reference group)
Personal screening among female physicians (see Appendix, Question 2): yes vs. no/no reply.
All ORs other than for personal screening behaviour of female physicians refer to the general model, including all clinically
active female and male physicians. The OR for personal screening behaviour is derived from the model including clinically
active female physicians only.
Discussion
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duced mammography screening programmes sev-
eral years ago statistically significant decreases in
breast cancer mortality are now being observed, in
agreement with the results of the intervention
studies [21–24]. Practitioners must be made aware
of this evidence. In our study we have shown that
believing in the life-prolonging effect of mam-
mography screening and having a positive attitude
towards a Swiss mammography screening pro-
gramme were positively associated with the likeli-
hood of prescribing mammography, in agreement
with the results of previous studies [25, 26].
Being well-informed about mammography
has a positive impact on attitudes towards the ben-
efits of this screening method and the likelihood
that it will be prescribed [27, 28]. Among the par-
ticipants in this study, an average of 37% self-re-
ported poor or very poor knowledge in this area.
This percentage was lowest for gynaecologists
(11%). But both the self-reported level of knowl-
edge and the fact of being a gynaecologist influ-
enced the likelihood of prescribing independently.
A higher mammography prescription rate [12, 29,
30] and greater knowledge of breast cancer epi-
demiology and the benefits of mammography
screening [31] among gynaecologists, as opposed
to internists or general practitioners, have been re-
ported in previous studies. Since postmenopausal
women are less likely to see a gynaecologist [32],
they are less likely to have a screening mammog-
raphy prescribed for them. According to Beaulieu,
30–40% of all postmenopausal women are either
not seeing a physician or not willing to take his/her
advice with regard to mammography screening
[10]. These women could be reached by screening
programmes with personal and regular invitations
to all women after age 50. The situation could be
additionally improved for these women by educat-
ing general practitioners and internists about the
benefits of mammography screening. The central
influence of physicians with regard to participation
rates in mammography screening programmes has
been reported in several studies [10–15]. 
The gender gap with regard to mammography
prescription was observed both bivariately and
multivariately, but reached statistical significance
only in the bivariate analysis. We also observed that
female physicians more commonly believed in the
life-prolonging effect of clinical breast examina-
tion than their male colleagues, but no informa-
tion is available with regard to gender differences
in the prescription of clinical breast examinations
in this study population. A greater likelihood of
prescribing screening mammography among fe-
male physicians is in agreement with previous
studies demonstrating a greater likelihood of hav-
ing a cancer screening exam among female patients
seeing a female physician, especially if the physi-
cian is a general practitioner or internist [29, 11,
33, 34]. Female physicians were found to prescribe
screening mammographies more frequently than
their male collegues [27]. 
The gender gap has also been observed in the
prescription of clinical breast examinations in
some [35] but not all studies [36]. Regular self-ex-
amination of one’s own breast was found to predict
the likelihood of a female physician’s prescribing
clinical breast examinations, possibly due to im-
proved confidence in accurately performing the
procedure [37, 38]. The more favourable attitude
of female as opposed to male physicians towards
prevention in general has been documented by
several studies [26, 28]. 
The prescription rate of screening mammog-
raphy for postmenopausal women may be under-
estimated in this study focusing on 50- to 65-year-
old physicians. The younger generation of physi-
cians is absent from the study population and gy-
naecologists are underrepresented. It is unknown
what percentage of postmenopausal women are
being counselled with regard to breast cancer pre-
vention by groups of physicians not represented in
this study population. Two investigations in the
Canton of Geneva in 1991 and 1995 revealed that
90% of all mammographies (including diagnostic
mammographies and mammographies for women
under 50) were prescribed by gynaecologists, as
compared to only 3% by general practitioners [39].
In our study, the likelihood of prescribing mam-
mography was only 60% even among gynaecolo-
gists. Overestimation of the prescription rate for
screening mammography by our study is a more
likely scenario, given the fact that the negative at-
titude towards this screening method was proba-
bly greater among non-participants. In addition,
several studies of male and female physicians have
documented “physician overreporting” [25, 40,
41]. Finally, the differences between diagnostic
and screening mammographies were often misun-
derstood, as evidenced by indications listed as rea-
sons for recommending screening mammography
(i.e. follow-up of positive clinical exam). 
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Most women after age 50 have no access to
quality-controlled mammography screening pro-
grammes in Switzerland. Given the current lack of
political and financial support for the establish-
ment of such programmes it is crucial to educate
male and female physicians, in particular general
practitioners and internists, as well as the political
community, on the subject of mammography
screening. 
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Appendix
Question 1: 
Attitude towards mammography screening
“It is planned that after 1.1.1999 biannual
screening mammographies for women above age
50 will be refunded by basic health insurance cov-
erage. Do you think that the benefits of mam-
mography screening (reduction of breast cancer
mortality: greater likelihood of breast conserving
therapy) outweigh its side effects (unnecessary
biopsies; prolongation of the time a woman knows
about the presence of breast cancer in the absence
of a life-prolonging effect) and that regular screen-
ing mammographies are justified for women aged
50 and over?”
– → Possible replies: yes – no – no opinion
Question 2: Personal screening behaviour 
“Do you undergo screening mammographies
at regular intervals (i.e. preventive mammogra-
phy in the absence of any symptoms or palpable
lesions)?“
– →Possible replies: yes – no
– • if “yes”: starting at what age, and at what
screening intervals?
– • if “no”: for what reasons?
Question 3: Prescription behaviour 
for screening mammography
“For patients without any indication of breast
disease, without palpable lesions, and without a
family history of breast cancer, do you generally
recommend screening mammography after a cer-
tain age?“
– →Possible replies: yes – no
– • if “yes”: for what age categories and at
what screening intervals?
– • if “no”: for what reasons? 
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